Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-((18)F)-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide

There is a critical need to develop and rigorously validate molecular imaging biomarkers to aid diagnosis and characterization of primary brain tumors. Elevated expression of translocator protein (TSPO) has been shown to predict disease progression and aggressive, invasive behavior in a variety of s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tang, Dewei, Hight, Matthew R., McKinley, Eliot T., Fu, Allie, Buck, Jason R., Smith, R. Adam, Tantawy, Mohammed Noor, Peterson, Todd E., Colvin, Daniel, Ansari, M. Sib, Nickels, Mike, Manning, H. Charles
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3391587/
https://ncbi.nlm.nih.gov/pubmed/22251555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.095653
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars